About the Journal

On this page: Aims & scope | About the Editors |  Editorial Board | Journal Metrics | Abstracted/indexed in | ISSN and eISSN | Newsfeeds | Disclaimer

Aims and scope

The Acta Pharmacologica Sinica (APS) sencourages submissions from all areas of pharmacology and the life sciences. Please go to Aims and scope page for more details.

About the Editors

Acta Pharmacologica Sinica is led by Editor-in-Chief Professor DING, Jian, please go to  about the editors’ page for further information.

Editorial Board

Acta Pharmacologica Sinica's international Editorial Board spans the breadth of the coverage of the journal –read more about the Editorial Board.

Journal Metrics

Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper.

The 2017 journal metrics for Acta Pharmacologica Sinica are as follows:

2-year Impact Factor 5-year Impact Factor Immediacy index Eigenfactor® score Article Influence Score Rank
3.562 3.773 1.283


0.855 53/171 Chemistry, Multidisciplinary
63/261 Pharmacology & Pharmacy

2017 Journal Citation Reports (Clarivate Analytics, 2018)

Abstracted/indexed in

Chemical Abstracts
CSA Bioengineering
CSA Medical Biotechnology
CSA Neuroscience
Current Contents/Life Sciences
Research Alert
EMBASE/Excerpta Medica
MEDLINE/Index Medicus


The international standard serial number (ISSN) for APS is 1671-4083, and the electronic international standard serial number (eISSN) is 1745-7254.


Acta Pharmacologica Sinica now provides its latest table of contents as an RSS web feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.

Receive Acta Pharmacologica Sinica's current issue table of contents.

Receive Acta Pharmacologica Sinica's AOP table of contents.

Find out more about RSS feeds, how to download an RSS reader and see all the newsfeeds offered by Springer Nature.


The editorial policies of this publication are determined jointly by its Editorial Board and Springer Nature in accordance with the legal and regulatory requirements of China.